Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickers.


Journal

Cytokine
ISSN: 1096-0023
Titre abrégé: Cytokine
Pays: England
ID NLM: 9005353

Informations de publication

Date de publication:
09 2023
Historique:
received: 17 04 2023
revised: 05 06 2023
accepted: 14 06 2023
medline: 11 8 2023
pubmed: 26 6 2023
entrez: 25 6 2023
Statut: ppublish

Résumé

To investigate the clinical significance of serum cytokine profiles for differentiating between Kawasaki disease (KD) and its mimickers. Patients with KD, including complete KD, KD shock syndrome (KDSS), and KD with macrophage activation syndrome (KD-MAS), and its mimickers, including multisystem inflammatory syndrome in children, toxic shock syndrome, and Yersinia pseudotuberculosis infection, were enrolled. Serum levels of interleukin (IL)-6, soluble tumor necrosis factor receptor type II (sTNF-RII), IL-10, IL-18, and chemokine (C-X-C motif) ligand 9 (CXCL9) were measured using enzyme-linked immunosorbent assay and compared them with clinical manifestations. Serum IL-6, sTNF-RII, and IL-10 levels were significantly elevated in patients with KDSS. Serum IL-18 levels were substantially elevated in patients with KD-MAS. Patients with KD-MAS and KD mimickers had significantly elevated serum CXCL9 levels compared with those with complete KD. Area under the receiver operating characteristic curve analysis showed that serum IL-6 was the most useful for differentiating KDSS from the others, IL-18 and CXCL9 for KD-MAS from complete KD, and CXCL9 for KD mimickers from complete KD and KD-MAS. Serum cytokine profiles may be useful for differentiating between KD and its mimickers.

Identifiants

pubmed: 37356260
pii: S1043-4666(23)00158-8
doi: 10.1016/j.cyto.2023.156280
pii:
doi:

Substances chimiques

Cytokines 0
Interleukin-6 0
Chemokine CXCL9 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

156280

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Shuya Kaneko (S)

Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Masaki Shimizu (M)

Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address: mshimizu.ped@tmd.ac.jp.

Asami Shimbo (A)

Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Hitoshi Irabu (H)

Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Koji Yokoyama (K)

Department of Pediatrics, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.

Kenji Furuno (K)

Department of, General Pediatrics and Interdisciplinary Medicine, Fukuoka Children's Hospital, Fukuoka, Japan.

Takayuki Tanaka (T)

Department of Pediatrics, Japanese Red Cross Otsu Hospital, Shiga, Japan.

Kazuyuki Ueno (K)

Department of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan.

Shuhei Fujita (S)

Department of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan.

Naomi Iwata (N)

Department of infection and immunology, Aichi Children's Health and Medical Center, Aichi, Japan.

Junya Fujimura (J)

Department of Pediatrics, Kakogawa Central City Hospital, Kakogawa, Japan.

Keiji Akamine (K)

Department of Nephrology and Rheumatology, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan.

Mao Mizuta (M)

Department of Rheumatology, Hyogo Prefectural Kobe Children's Hospital, Hyogo, Japan.

Yasuo Nakagishi (Y)

Department of Rheumatology, Hyogo Prefectural Kobe Children's Hospital, Hyogo, Japan.

Toshinori Minato (T)

Department of Pediatrics, Toyooka Hospital, Hyogo, Japan.

Kenichi Watanabe (K)

Department of Pediatrics, Japanese Red Cross Nagaoka Hospital, Nagano, Japan.

Anna Kobayashi (A)

Department of Pediatrics, University of Yamanashi, Yamanashi, Japan.

Takuya Endo (T)

Department of Pediatrics, Saitama Medical University, Saitama, Japan.

Katsuhiko Tabata (K)

Department of Pediatrics, Saitama Medical University, Saitama, Japan.

Masaaki Mori (M)

Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Tomohiro Morio (T)

Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH